Albert David

67
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE155C01010
  • NSEID: ALBERTDAVD
  • BSEID: 524075
INR
801.00
-15.7 (-1.92%)
BSENSE

Aug 10

BSE+NSE Vol: 27.41 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -3.52% vs -4.61% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 81.42% vs -93.27% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 430.80% vs 26.70% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -108.69% vs -77.19% in Mar 2025

Compare Profit and Loss Results of Albert David
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
333.00
368.00
-35.00
-9.51%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
34.00
-34.00
-100.00%
Net Sales
333.00
333.00
0.00
0.00%
Expenditure (Ex Depriciation)
Stock Adjustments
4.00
4.00
0.00
0.00%
Raw Materials Consumed
108.00
164.00
-56.00
-34.15%
Power & Fuel Cost
15.00
27.00
-12.00
-44.44%
Employee Cost
102.00
45.00
57.00
126.67%
Operating Expenses
8.00
28.00
-20.00
-71.43%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
32.00
4.00
28.00
700.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
23.00
7.00
16.00
228.57%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
327.00
289.00
38.00
13.15%
Operating Profit (PBDIT) excl Other Income
5.00
44.00
-39.00
-88.64%
Other Income
7.00
3.00
4.00
133.33%
Operating Profit (PBDIT)
13.00
48.00
-35.00
-72.92%
Interest
2.00
7.00
-5.00
-71.43%
Profit before Depriciation and Tax
10.00
40.00
-30.00
-75.00%
Depreciation
9.00
10.00
-1.00
-10.00%
Profit Before Taxation & Exceptional Items
0.00
30.00
-30.00
-100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
30.00
-30.00
-100.00%
Provision for Tax
2.00
8.00
-6.00
-75.00%
Profit After Tax
-1.00
21.00
-22.00
-104.76%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
249.00
101.00
148.00
146.53%
Profit Available for appropriations
247.00
122.00
125.00
102.46%
Appropriations
247.00
122.00
125.00
102.46%
Equity Dividend (%)
50%
15%
35.00
Earnings Per Share
-2.62
70.69
-73.31
-103.71%
Profit And Loss - Net Sales
Net Sales 333.60 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -3.52% vs -4.61% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.74 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 81.42% vs -93.27% in Mar 2025

Profit And Loss - Interest
Interest 2.90 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 430.80% vs 26.70% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax -1.49 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -108.69% vs -77.19% in Mar 2025